Literature DB >> 6146220

The paracortical area in dermatopathic lymphadenitis and other reactive conditions of the lymph node.

J J van der Oord, C de Wolf-Peeters, R de Vos, V J Desmet.   

Abstract

We compared the paracortical area in 4 cases of dermatopathic lymphadenitis (DL) with the same area in 11 cases of various other reactive conditions of the lymph node by immuno- and enzymehistochemical techniques. In addition, electron microscopy was performed on three cases of DL. The paracortical nodules in DL proved to be composed of a variable number of dendritic, OKT6+ OKIa + ATPase+ cells, admixed with helper T-lymphocytes. All other lymph nodes studied lacked dendritic OKT6+ cells, whereas OKIa positivity was found in the cortical (follicular centers and mantle zones) and paracortical area (lymphocytes and scattered dendritic cells). Short incubation for ATPase revealed a paracortical, pericellular staining pattern in cases of DL, whereas in all other cases this staining pattern was observed only after long incubation times. On electron microscopy, three types of dendritic cells were found in DL, namely interdigitating reticulum cells ( IDRC ). Langerhans cells (LC) and macrophages. Intermediate forms between IDRC and LC, containing a few Birbeck granules and a well developed rough endoplasmic reticulum, were found. It is suggested that immunoreactivity for the monoclonal antibody OKT6 is restricted to cases of DL, and is due to the appearance of dendritic cells that have LC-characteristics. These cells either arrive from the skin along afferent lymph vessels, or are the result of a local transformation process of IDRC that acquire LC-characteristics, i.e. OKT6 immunoreactivity and Birbeck granules.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146220     DOI: 10.1007/bf02889871

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  7 in total

1.  Nodular alteration of the paracortical area. An in situ immunohistochemical analysis of primary, secondary, and tertiary T-nodules.

Authors:  J J van den Oord; C De Wolf-Peeters; V J Desmet; K Takahashi; Y Ohtsuki; T Akagi
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

2.  [Loss of appetite, night sweats, eczema, and axillary and inguinal lymph node swelling in a 28-year-old man].

Authors:  U Wahl; R Stranzenbach; I Tischoff; A Tannapfel; R Stadler; F Ernst
Journal:  Internist (Berl)       Date:  2014-03       Impact factor: 0.743

3.  Cathepsin D and E co-expression in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) and Langerhans' cell histiocytosis: further evidences of a phenotypic overlap between these histiocytic disorders.

Authors:  M Paulli; A C Feller; E Boveri; S Kindl; E Berti; R Rosso; H Merz; F Facchetti; C Gambini; F Bonetti
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  The Omenn's syndrome: histological, immunohistochemical and ultrastructural evidence for a partial T cell deficiency evolving in an abnormal proliferation of T lymphocytes and S-100 +/T-6 + Langerhans-like cells.

Authors:  L P Ruco; A Stoppacciaro; F Pezzella; M Mirolo; S Uccini; P Barsotti; A M Cassano; A L Boner; L Businco; A Di Fazio
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

5.  Phenotypic modulation of the stromal reticular network in normal and neoplastic lymph nodes: tissue transglutaminase reveals coordinate regulation of multiple cell types.

Authors:  Vilmos A Thomazy; Francisco Vega; L Jeffrey Medeiros; Peter J Davies; Dan Jones
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

Review 6.  Non-neoplastic histiocytic and dendritic cell disorders in lymph nodes.

Authors:  Caoimhe Egan; Elaine S Jaffe
Journal:  Semin Diagn Pathol       Date:  2017-11-03       Impact factor: 3.464

7.  Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B).

Authors:  Derek Murphy; Jeremy Parker; Minglong Zhou; Faisal M Fadlelmola; Christian Steidl; Aly Karsan; Randy D Gascoyne; Hong Chen; Diponkar Banerjee
Journal:  Mol Cancer       Date:  2010-01-26       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.